Richard Payerchin is editor of Medical Economics.
Health effects from partner and child abuse; vaccine hesitancy; eliminating food waste – Morning Medical Update
The top news stories in primary care today.
Medicare leaders target PBMs, insurance coverage, pharmacy competition
Prescription drug prices, vaccine costs are also key issues.
Prescription drug rebates are coming: CMS
In 2024, beneficiaries could see savings per dose, according to new guidance on price increases relative to inflation.
U.S. health care spending hits $4.5 trillion in 2022
Physicians, hospitals, prescription drugs at top of list for expenditures.
COVID-19 booster approvals; fighting opioid use disorder; Social Security asks for money back – Morning Medical Update
USPSTF reviews weight loss interventions for children and teens
BMI is a ‘crude measure,’ but it appears youths are not meeting diet and exercise recommendations.
HHS: We must seize the promise and manage risks of AI, information chief says
House committee examines future of artificial intelligence in health care, energy and commerce.
Concussions in tennis; malnutrition and body mass; federal money for home and community-based services – Morning Medical Update
Health care legislation would disclose pricing information, enact site-neutral payment, regulate PBMs
House approves landmark ‘Lower Costs, More Transparency Act.’
Hypertension in couples; physician birth difficulties; Rocky Mountain spotted fever – Morning Medical Update
American Telemedicine Association announces new Clinician Council
Group advocates for telehealth availability and responsible use.
Healthy holidays; avoid this pathogen; uniting for health care competition – Morning Medical Update
Committee sends 19 health care bills for full House consideration
Law could change Medicare Physician Fee Schedule, affecting reimbursement to doctors.
Health care a job leader for November
Federal figures show growth across some industries and declines in others.
Support for primary care; antiobesity medication use; scanning sewage for viruses – Morning Medical Update
President targets high prescription drug prices with ‘march-in’ authority
Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.
MedPAC mulls over physician compensation through Medicare
December meeting has two days of discussion planned.
Health groups rip White House for delaying ban on menthol cigarettes
Move would save lives, but administration punts to 2024.
Christmas decoration injuries; aging due to organ donation; global warming and health care – Morning Medical Update
At-home treatment for flu, COVID-19 expands nationwide
National Institutes of Health announce program as potential model for future care.
AI in health care to be part of upcoming House committee meeting
Representatives examining how administration experts develop American leadership in technology.
Insurance companies manipulating generic prescription drug prices in Medicare: Study
‘The results are alarming,’ with potential financial effects for patients and pharmacies, researchers say.
Exercise for older adults; feds support reproductive rights; life ends but the mail goes on – Morning Medical Update
New FDA rules on lab tests could hurt patient health, experts say
Regulators ponder declaration about in vitro diagnostic products.
Potential syringe failures; Senate takes on prescription drug shortages; positive attitude may reduce dementia risk – Morning Medical Update
Flu, RSV vaccines can be given safely at the same time, study says
Double dose against respiratory illness may be more convenient for patients.
Flu vaccines help heart health; respiratory illness on the rise; CMS extends application period for new payment model – Morning Medical Update
CMS extends application deadline for new Making Care Primary program
Value-based care to launch in eight states in July next year.
Potential changes in HIV screening; $148M in alleged urine testing fraud; Medicare coverage for insulin – Morning Medical Update
‘CDC is a critical national security asset’
New director testifies on her plans, agency strengths, and areas for improvement before House subcommittee.